Treatment of herpes simplex encephalitis.
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003399:Craniotomy; D003561:Cytarabine / Q000627:therapeutic use; D004660:Encephalitis / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality / Q000628:therapy; D005260:Female; D006561:Herpes Simplex / Q000150:complications*; D006801:Humans; D007065:Idoxuridine / Q000009:adverse effects / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D012737:Sex Factors; D013256:Steroids / Q000627:therapeutic use
D013256:Steroids; D003561:Cytarabine; D000324:Adrenocorticotropic Hormone; D007065:Idoxuridine